Credit Suisse Ag Ptc Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 83,635 shares of PTCT stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,635

Previous 83,635 -0.0%

Holding current value

$3.02 Million

Previous $2.3 Million 5.56%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$18.07 - $29.37 $197,703 - $321,337	10,941 Added 15.05%	83,635 $2.3 Million
Q3 2023 Nov 13, 2023	SELL	$22.41 - $41.99 $377,182 - $706,733	-16,831 Reduced 18.8%	72,694 $1.63 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $980,710 - $1.43 Million	24,275 Added 37.2%	89,525 $3.64 Million
Q1 2023 May 10, 2023	BUY	$38.16 - $48.86 $154,891 - $198,322	4,059 Added 6.63%	65,250 $3.16 Million
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $45,299 - $74,021	-1,351 Reduced 2.16%	61,191 $2.34 Million
Q3 2022 Nov 10, 2022	SELL	$41.85 - $53.85 $192,719 - $247,979	-4,605 Reduced 6.86%	62,542 $3.14 Million
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $96,409 - $170,336	-3,766 Reduced 5.31%	67,147 $2.69 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $314,535 - $420,890	9,437 Added 15.35%	70,913 $2.65 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $141,369 - $167,356	-3,998 Reduced 6.11%	61,476 $2.45 Million
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $664,588 - $803,396	-17,957 Reduced 21.52%	65,474 $2.44 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $542,912 - $706,287	14,306 Added 20.7%	83,431 $3.53 Million
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $1.78 Million - $2.62 Million	-38,060 Reduced 35.51%	69,125 $3.27 Million
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $919,297 - $1.3 Million	19,168 Added 21.78%	107,185 $6.54 Million
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $775,103 - $974,127	-17,069 Reduced 16.24%	88,017 $4.12 Million
Q2 2020 Aug 12, 2020	BUY	$42.56 - $54.98 $995,052 - $1.29 Million	23,380 Added 28.61%	105,086 $5.33 Million
Q1 2020 May 13, 2020	SELL	$32.37 - $59.36 $568,870 - $1.04 Million	-17,574 Reduced 17.7%	81,706 $3.65 Million
Q4 2019 Feb 12, 2020	SELL	$32.22 - $50.07 $12.9 Million - $20 Million	-400,014 Reduced 80.12%	99,280 $4.77 Million
Q3 2019 Nov 12, 2019	BUY	$33.82 - $48.17 $15.7 Million - $22.3 Million	462,858 Added 1270.33%	499,294 $16.9 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $298,413 - $379,125	-8,425 Reduced 18.78%	36,436 $1.64 Million
Q1 2019 May 14, 2019	BUY	$28.09 - $39.49 $482,642 - $678,517	17,182 Added 62.08%	44,861 $1.69 Million
Q4 2018 Feb 13, 2019	SELL	$29.83 - $46.51 $1.63 Million - $2.54 Million	-54,653 Reduced 66.38%	27,679 $951,000
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $1.37 Million - $1.94 Million	40,549 Added 97.05%	82,332 $3.87 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $454,581 - $846,901	-17,688 Reduced 29.74%	41,783 $1.41 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $360,356 - $672,625	20,639 Added 53.15%	59,471 $1.61 Million
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $285,146 - $393,442	-18,834 Reduced 32.66%	38,832 $647,000
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $201,299 - $258,779	11,975 Added 26.21%	57,666 $1.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	45,691	45,691 $838,000

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.58B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account